TY - JOUR
T1 - Comparison of the internal state scale to clinician-administered scales in asthma patients receiving corticosteroid therapy
AU - Brown, E. Sherwood
AU - Bauer, Mark S.
AU - Suppes, Trisha
AU - Khan, David A.
AU - Carmody, Thomas
N1 - Funding Information:
Supported, in part, by the National Alliance for Research on Schizophrenia and Depression (NARSAD), the Sarah M. and Charles E. Seay Center for Basic and Applied Research in Psychiatric Illness, John Schemerhorn Psychiatric Fund (ESB), the Theodore and Vada Stanley Foundation (ESB, TS), and VAHSR & D Grant # DEV-97015 (MSB). The authors thank Carol Nunley for manuscript preparation, Susan Mahadi, M.Ed. for proofreading, and Kenneth Z. Altshuler, M.D., Stanton Sharp Distinguished Chair, Professor and Chairman, Department of Psychiatry, UT Southwestern Medical Center at Dallas for administrative assistance.
PY - 2000/5
Y1 - 2000/5
N2 - Mood symptoms are reported frequently in asthma patients, particularly during corticosteroid therapy. This investigation compared the Internal State Scale (ISS), a self-report measure of symptoms of mania and depression, to the Hamilton Rating Scale for Depression (HRSD), Young Mania Rating Scale (YMRS), and Brief Psychiatric Rating Scale (BPRS) in a group of asthma patients (n=60 at baseline) before, during, and after a 1-2 week burst of prednisone. The depression and well being subscales of the ISS correlated well with HDRS scores. The perceived conflict subscale correlated with the BPRS scores. However, none of the ISS subscales correlated consistently and specifically with the YMRS in this population. Possible explanations for differences observed in bipolar versus asthma patients given the ISS are discussed. These data suggest the ISS may be a useful tool for depression symptoms and overall psychopathology in asthma patients and in patients receiving corticosteroid therapy. However, its ability may be attenuated outside of the population for which it was designed. Copyright (C) 2000 Elsevier Science Inc.
AB - Mood symptoms are reported frequently in asthma patients, particularly during corticosteroid therapy. This investigation compared the Internal State Scale (ISS), a self-report measure of symptoms of mania and depression, to the Hamilton Rating Scale for Depression (HRSD), Young Mania Rating Scale (YMRS), and Brief Psychiatric Rating Scale (BPRS) in a group of asthma patients (n=60 at baseline) before, during, and after a 1-2 week burst of prednisone. The depression and well being subscales of the ISS correlated well with HDRS scores. The perceived conflict subscale correlated with the BPRS scores. However, none of the ISS subscales correlated consistently and specifically with the YMRS in this population. Possible explanations for differences observed in bipolar versus asthma patients given the ISS are discussed. These data suggest the ISS may be a useful tool for depression symptoms and overall psychopathology in asthma patients and in patients receiving corticosteroid therapy. However, its ability may be attenuated outside of the population for which it was designed. Copyright (C) 2000 Elsevier Science Inc.
UR - http://www.scopus.com/inward/record.url?scp=0034611988&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034611988&partnerID=8YFLogxK
U2 - 10.1016/S0163-8343(00)00075-X
DO - 10.1016/S0163-8343(00)00075-X
M3 - Article
C2 - 10880712
AN - SCOPUS:0034611988
SN - 0163-8343
VL - 22
SP - 180
EP - 183
JO - General Hospital Psychiatry
JF - General Hospital Psychiatry
IS - 3
ER -